Next, we performed global gene expression profiling to investigate the effects of targeting LSD1 and/or G9a in ESCC cells using either pharmacological or genetic approaches combined with RNA sequencing (RNA-seq) analysis. Here, EHMT2 is linked to esophageal squamous cell carcinoma.